Abstract
Summary
The global Ophthalmic Medicine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Ophthalmic Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Ophthalmic Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Ophthalmic Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Ophthalmic Medicine players cover Novaliq, Shenyang Xingqi Pharmaceutical Co.,Ltd., Zhejiang Shapuaisi Pharmaceutical, Chengdu Kanghong Pharmaceutical Group, Santen Pharmaceutica, Bausch Health, Alcon NV and Mentholatum, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
There are several diseases that can affect the eyes, and often, the kind of treatment required is medication that you put directly into them. It is called “ophthalmic” and often comes in the form of drops, gel or ointment.
LPI (LP Information)' newest research report, the “Ophthalmic Medicine Industry Forecast” looks at past sales and reviews total world Ophthalmic Medicine sales in 2022, providing a comprehensive analysis by region and market sector of projected Ophthalmic Medicine sales for 2023 through 2029. With Ophthalmic Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ophthalmic Medicine industry.
This Insight Report provides a comprehensive analysis of the global Ophthalmic Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ophthalmic Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Ophthalmic Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ophthalmic Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ophthalmic Medicine.
This report presents a comprehensive overview, market shares, and growth opportunities of Ophthalmic Medicine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Eye Drops
Eye Ointment
Gelling Agent
Tablet
Injection
Segmentation by application
Anti-fatigue and Dryness
Cataract
Anti-infective
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Novaliq
Shenyang Xingqi Pharmaceutical Co.,Ltd.
Zhejiang Shapuaisi Pharmaceutical
Chengdu Kanghong Pharmaceutical Group
Santen Pharmaceutica
Bausch Health
Alcon NV
Mentholatum
Key Questions Addressed in this Report
What is the 10-year outlook for the global Ophthalmic Medicine market?
What factors are driving Ophthalmic Medicine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Ophthalmic Medicine market opportunities vary by end market size?
How does Ophthalmic Medicine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
United States market for Ophthalmic Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Ophthalmic Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Ophthalmic Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Ophthalmic Medicine players cover Novaliq, Shenyang Xingqi Pharmaceutical Co.,Ltd., Zhejiang Shapuaisi Pharmaceutical, Chengdu Kanghong Pharmaceutical Group, Santen Pharmaceutica, Bausch Health, Alcon NV and Mentholatum, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
There are several diseases that can affect the eyes, and often, the kind of treatment required is medication that you put directly into them. It is called “ophthalmic” and often comes in the form of drops, gel or ointment.
LPI (LP Information)' newest research report, the “Ophthalmic Medicine Industry Forecast” looks at past sales and reviews total world Ophthalmic Medicine sales in 2022, providing a comprehensive analysis by region and market sector of projected Ophthalmic Medicine sales for 2023 through 2029. With Ophthalmic Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ophthalmic Medicine industry.
This Insight Report provides a comprehensive analysis of the global Ophthalmic Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ophthalmic Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Ophthalmic Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ophthalmic Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ophthalmic Medicine.
This report presents a comprehensive overview, market shares, and growth opportunities of Ophthalmic Medicine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Eye Drops
Eye Ointment
Gelling Agent
Tablet
Injection
Segmentation by application
Anti-fatigue and Dryness
Cataract
Anti-infective
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Novaliq
Shenyang Xingqi Pharmaceutical Co.,Ltd.
Zhejiang Shapuaisi Pharmaceutical
Chengdu Kanghong Pharmaceutical Group
Santen Pharmaceutica
Bausch Health
Alcon NV
Mentholatum
Key Questions Addressed in this Report
What is the 10-year outlook for the global Ophthalmic Medicine market?
What factors are driving Ophthalmic Medicine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Ophthalmic Medicine market opportunities vary by end market size?
How does Ophthalmic Medicine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Ophthalmic Medicine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Ophthalmic Medicine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Ophthalmic Medicine by Country/Region, 2018, 2022 & 2029
2.2 Ophthalmic Medicine Segment by Type
2.2.1 Eye Drops
2.2.2 Eye Ointment
2.2.3 Gelling Agent
2.2.4 Tablet
2.2.5 Injection
2.3 Ophthalmic Medicine Sales by Type
2.3.1 Global Ophthalmic Medicine Sales Market Share by Type (2018-2023)
2.3.2 Global Ophthalmic Medicine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Ophthalmic Medicine Sale Price by Type (2018-2023)
2.4 Ophthalmic Medicine Segment by Application
2.4.1 Anti-fatigue and Dryness
2.4.2 Cataract
2.4.3 Anti-infective
2.5 Ophthalmic Medicine Sales by Application
2.5.1 Global Ophthalmic Medicine Sale Market Share by Application (2018-2023)
2.5.2 Global Ophthalmic Medicine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Ophthalmic Medicine Sale Price by Application (2018-2023)
3 Global Ophthalmic Medicine by Company
3.1 Global Ophthalmic Medicine Breakdown Data by Company
3.1.1 Global Ophthalmic Medicine Annual Sales by Company (2018-2023)
3.1.2 Global Ophthalmic Medicine Sales Market Share by Company (2018-2023)
3.2 Global Ophthalmic Medicine Annual Revenue by Company (2018-2023)
3.2.1 Global Ophthalmic Medicine Revenue by Company (2018-2023)
3.2.2 Global Ophthalmic Medicine Revenue Market Share by Company (2018-2023)
3.3 Global Ophthalmic Medicine Sale Price by Company
3.4 Key Manufacturers Ophthalmic Medicine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ophthalmic Medicine Product Location Distribution
3.4.2 Players Ophthalmic Medicine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Ophthalmic Medicine by Geographic Region
4.1 World Historic Ophthalmic Medicine Market Size by Geographic Region (2018-2023)
4.1.1 Global Ophthalmic Medicine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Ophthalmic Medicine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Ophthalmic Medicine Market Size by Country/Region (2018-2023)
4.2.1 Global Ophthalmic Medicine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Ophthalmic Medicine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Ophthalmic Medicine Sales Growth
4.4 APAC Ophthalmic Medicine Sales Growth
4.5 Europe Ophthalmic Medicine Sales Growth
4.6 Middle East & Africa Ophthalmic Medicine Sales Growth
5 Americas
5.1 Americas Ophthalmic Medicine Sales by Country
5.1.1 Americas Ophthalmic Medicine Sales by Country (2018-2023)
5.1.2 Americas Ophthalmic Medicine Revenue by Country (2018-2023)
5.2 Americas Ophthalmic Medicine Sales by Type
5.3 Americas Ophthalmic Medicine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ophthalmic Medicine Sales by Region
6.1.1 APAC Ophthalmic Medicine Sales by Region (2018-2023)
6.1.2 APAC Ophthalmic Medicine Revenue by Region (2018-2023)
6.2 APAC Ophthalmic Medicine Sales by Type
6.3 APAC Ophthalmic Medicine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Ophthalmic Medicine by Country
7.1.1 Europe Ophthalmic Medicine Sales by Country (2018-2023)
7.1.2 Europe Ophthalmic Medicine Revenue by Country (2018-2023)
7.2 Europe Ophthalmic Medicine Sales by Type
7.3 Europe Ophthalmic Medicine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Ophthalmic Medicine by Country
8.1.1 Middle East & Africa Ophthalmic Medicine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Ophthalmic Medicine Revenue by Country (2018-2023)
8.2 Middle East & Africa Ophthalmic Medicine Sales by Type
8.3 Middle East & Africa Ophthalmic Medicine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ophthalmic Medicine
10.3 Manufacturing Process Analysis of Ophthalmic Medicine
10.4 Industry Chain Structure of Ophthalmic Medicine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ophthalmic Medicine Distributors
11.3 Ophthalmic Medicine Customer
12 World Forecast Review for Ophthalmic Medicine by Geographic Region
12.1 Global Ophthalmic Medicine Market Size Forecast by Region
12.1.1 Global Ophthalmic Medicine Forecast by Region (2024-2029)
12.1.2 Global Ophthalmic Medicine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Ophthalmic Medicine Forecast by Type
12.7 Global Ophthalmic Medicine Forecast by Application
13 Key Players Analysis
13.1 Novaliq
13.1.1 Novaliq Company Information
13.1.2 Novaliq Ophthalmic Medicine Product Portfolios and Specifications
13.1.3 Novaliq Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novaliq Main Business Overview
13.1.5 Novaliq Latest Developments
13.2 Shenyang Xingqi Pharmaceutical Co.,Ltd.
13.2.1 Shenyang Xingqi Pharmaceutical Co.,Ltd. Company Information
13.2.2 Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Product Portfolios and Specifications
13.2.3 Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Shenyang Xingqi Pharmaceutical Co.,Ltd. Main Business Overview
13.2.5 Shenyang Xingqi Pharmaceutical Co.,Ltd. Latest Developments
13.3 Zhejiang Shapuaisi Pharmaceutical
13.3.1 Zhejiang Shapuaisi Pharmaceutical Company Information
13.3.2 Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Product Portfolios and Specifications
13.3.3 Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Zhejiang Shapuaisi Pharmaceutical Main Business Overview
13.3.5 Zhejiang Shapuaisi Pharmaceutical Latest Developments
13.4 Chengdu Kanghong Pharmaceutical Group
13.4.1 Chengdu Kanghong Pharmaceutical Group Company Information
13.4.2 Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Product Portfolios and Specifications
13.4.3 Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Chengdu Kanghong Pharmaceutical Group Main Business Overview
13.4.5 Chengdu Kanghong Pharmaceutical Group Latest Developments
13.5 Santen Pharmaceutica
13.5.1 Santen Pharmaceutica Company Information
13.5.2 Santen Pharmaceutica Ophthalmic Medicine Product Portfolios and Specifications
13.5.3 Santen Pharmaceutica Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Santen Pharmaceutica Main Business Overview
13.5.5 Santen Pharmaceutica Latest Developments
13.6 Bausch Health
13.6.1 Bausch Health Company Information
13.6.2 Bausch Health Ophthalmic Medicine Product Portfolios and Specifications
13.6.3 Bausch Health Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Bausch Health Main Business Overview
13.6.5 Bausch Health Latest Developments
13.7 Alcon NV
13.7.1 Alcon NV Company Information
13.7.2 Alcon NV Ophthalmic Medicine Product Portfolios and Specifications
13.7.3 Alcon NV Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Alcon NV Main Business Overview
13.7.5 Alcon NV Latest Developments
13.8 Mentholatum
13.8.1 Mentholatum Company Information
13.8.2 Mentholatum Ophthalmic Medicine Product Portfolios and Specifications
13.8.3 Mentholatum Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Mentholatum Main Business Overview
13.8.5 Mentholatum Latest Developments
14 Research Findings and Conclusion